NH TherAguix
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $14M
Investors
- 4
About NH TherAguix
Founded in 2015 in France, NH TherAguix SAS focuses on the advancement of nanomedicine for cancer therapies.NH TherAguix specializes in developing innovative nanomedicine technologies aimed at enhancing precision radiotherapy for cancer treatment.1. Target markets for expansion include Europe, North America, and Asia, where there is a significant demand for advanced cancer therapies.
Who invested in NH TherAguix
4 investors across 3 rounds
See all investors in NH TherAguix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NH TherAguix
Who invested in NH TherAguix?
NH TherAguix has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NH TherAguix raised?
NH TherAguix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NH TherAguix last raise money?
NH TherAguix's most recent round on record is a Series A, in Jun 2021.
What does NH TherAguix do?
Founded in 2015 in France, NH TherAguix SAS focuses on the advancement of nanomedicine for cancer therapies.
Where is NH TherAguix headquartered?
NH TherAguix is headquartered in France.
Which VCs invest in companies like NH TherAguix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at NH TherAguix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like NH TherAguix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.